Besides, especially in GBM, genomic rearrangement caused by EGFR Amp increases the occurrence of EGFRvIII, which could activate PI3K/AKT and other downstream pathways independent of extracellular ligand, exerting pro-tumorigenic effects (Yang et al., 2017). The gene discussed is EGFR; the disease is glioblastoma.